12. Doxazosin- is efficacious in the treatment of hypertension and BPH. It has longer
half-life of about 22 hours.
13. Captopril- inhibit the converting enzyme peptidyl dipeptidase that hydrolyses
angiotensin i to angiotensin ii and inactivates bradykinin.
15. Esmolol- is a b1-selective blocker that is rapidly metabolized via hydrolysis by red
blood cell esterases.
17. Labetalol- because of its combines alpha and beta blocking activity, it is useful in
treating the hypertension of pheochromocytoma and hypertensive emergencies.
18. Losartan- Block AT1 angiotensin receptors. Same as ACE inhibitors but no
increase in bradykinin.
30. Reserpine- blocks the ability of aminergic transmitter vesicles to take up and store
biogenic amines, by interfering with the vmat.
ACROSS
6. Verapamil- blocks both activated and inactivated L-type calcium channels. It can
cause peripheral vasodilation which may be beneficial on hypertension.
19. Clonidine- is lipid-soluble and rapidly enters the brain from the circulation. It
reduces blood pressure in the supine position and only rarely caused postural
hypotension.
22. Aliskerin- inhibits enyme activity of renin. Reduces angiotensin i and ii and
aldosterone.
23. Diazoxide- similar to thiazide diuretics but has no diuretic activity. It bound
extensively to serum albumin and vascular tissue.
24. Nebivolol- is a b1-selective blocker with vasodilating properties that are not
mediated by alpha blockade.
27. Clevidipine- is a newer member of the calcium channel blockers that is formulated
for intravenous only.
7. A ganglion-blocking agent
12. is efficacious in the treatment of hypertension and BPH. It has longer half-life of
about 22 hours.
13. inhibit the converting enzyme peptidyl dipeptidase that hydrolyses angiotensin i to
angiotensin ii and inactivates bradykinin.
15. is a b1-selective blocker that is rapidly metabolized via hydrolysis by red blood cell
esterases.
17. because of its combines alpha and beta blocking activity, it is useful in treating the
hypertension of pheochromocytoma and hypertensive emergencies.
18. Block AT1 angiotensin receptors. Same as ACE inhibitors but no increase in
bradykinin.
30. blocks the ability of aminergic transmitter vesicles to take up and store biogenic
amines, by interfering with the vmat.
ACROSS
3. high doses, it can produce profound sympathoplegia. It is too polar to enter the
central nervous system. As a result, this drug has none of the central effects seen with
many other antihypertensive agents. Interferes with amine release and replaces
norepinephrine in vesicles.
6. blocks both activated and inactivated L-type calcium channels. It can cause
peripheral vasodilation which may be beneficial on hypertension.
19. is lipid-soluble and rapidly enters the brain from the circulation. It reduces blood
pressure in the supine position and only rarely caused postural hypotension.
22. inhibits enyme activity of renin. Reduces angiotensin i and ii and aldosterone.
23. similar to thiazide diuretics but has no diuretic activity. It bound extensively to
serum albumin and vascular tissue.
24. is a b1-selective blocker with vasodilating properties that are not mediated by
alpha blockade.
27. is a newer member of the calcium channel blockers that is formulated for
intravenous only.
28. is a very efficacious orally vasodilator. Like hydralazine, it dilates arterioles but not
veins.